Status:
UNKNOWN
Risk Prediction Model of Preeclampsia
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Beijing Forestry university
Conditions:
Preeclampsia
Preeclampsia Severe
Eligibility:
FEMALE
20-50 years
Brief Summary
Preeclampsia is the main cause of increased maternal and perinatal mortality during pregnancy. Preeclampsia is mainly manifested as hypertension, urine protein, or damage symptoms of other target orga...
Detailed Description
Research objects: This is a prospective study. About 2000 pregnant women who will take regular prenatal examination in the Department of Obstetrics, Peking University Third Hospital. During 6-8 weeks...
Eligibility Criteria
Inclusion
- Pregnant women aged 20-50 years old, primiparas or postparturas,
- and undergoing prenatal examination in Peking University Third Hospital ;
- and deliver live fetuses or stillborn fetuses with normal appearance after 24 weeks.
Exclusion
- The pregant woman has tumor ,
- or has severe fetal abnormality,
- or terminates the pregnancy before 24 weeks,
- or the fetus dies.
Key Trial Info
Start Date :
February 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04794855
Start Date
February 20 2021
End Date
December 1 2024
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191